Canopus Biopharma (CE) Aktie - CBIA

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,000001

Gebot

0,00

Fragen

0,00

Volumen

0,00 Tagesbereich 0,00

0,000001 52-Wochen-Bereich 0,00055

Handelsende

0,000001

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

22.014.673

Finanzvolumen

VWAP

Form 1-A-W - Withdrawal of offering statement [Regulation A]

Form 1-A POS -

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 253G2 -

Form 253G1 -

Form QUALIF - Notice of Qualification [Regulation A]

Form 1-A POS -

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study PR Newswire LOS ANGELES, Dec. 19, 2014 LOS ANGELES...

Canopus BioPharma Inc. Announces Results from Compassionate Study in Hepatitis C patients in China

Canopus BioPharma Inc. Announces Results from Compassionate Study in Hepatitis C patients in China - Results Confirm Efficacy and Safety of an...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-0.000149	-99.3333333333	0.00015	0.0002	1.0E-6	22014673	0.00016103	CS
26	-0.000149	-99.3333333333	0.00015	0.0002	1.0E-6	13020317	0.00015092	CS
52	-0.000499	-99.8	0.0005	0.00055	1.0E-6	45852687	0.00031682	CS
156	-0.037499	-99.9973333333	0.0375	0.224	1.0E-6	57933131	0.00058503	CS
260	-0.105999	-99.9990566038	0.106	0.59975	1.0E-6	44758370	0.00058778	CS

CBIA - Frequently Asked Questions (FAQ)

What is the current Canopus Biopharma (CE) share price?

The current share price of Canopus Biopharma (CE) is US$ 0,000001

What is the 1 year trading range for Canopus Biopharma (CE) share price?

Canopus Biopharma (CE) has traded in the range of US$ 0,000001 to US$ 0,00055 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
PERTPermanent Technologies Inc (CE)	US$ 0,0001 (9.900,00%)	30k
INTKIndustrial Nanotech Inc (PK)	US$ 0,0001 (9.900,00%)	20k
GBXIGBX International Group Inc (CE)	US$ 0,0001 (9.900,00%)	4k
CBGLCannabis Global Inc (PK)	US$ 0,0001 (9.900,00%)	3,79k
ANTHAnthera Pharmaceuticals Inc (CE)	US$ 0,0001 (9.900,00%)	1,59k
FBECFBEC Worldwide Inc (CE)	US$ 0,000001 (-99,80%)	10k
VAXXVaxxinity Inc (CE)	US$ 0,0001 (-99,80%)	1k
PLPLPlandai Biotechnology Inc (PK)	US$ 0,000001 (-99,00%)	200k
MDCNMedican Enterprises Inc (PK)	US$ 0,000001 (-99,00%)	39k
GNCAQGenocea Biosciences Inc (CE)	US$ 0,000001 (-99,00%)	375
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0,0024 (0,00%)	19,95M
RDARRaadr Inc (PK)	US$ 0,0008 (14,29%)	13,83M
PGPMPilgrim Petroleum Corporation (CE)	US$ 0,000001 (0,00%)	11,03M
DPLSDarkPulse Inc (PK)	US$ 0,00034 (13,33%)	8,82M
RONNRonn Motor Group Inc (PK)	US$ 0,0002 (0,00%)	7,12M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Canopus Biopharma Inc (CE) (CBIA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

CBIA Neueste Nachrichten

Form 1-A-W - Withdrawal of offering statement [Regulation A]

Form 1-A POS -

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 253G2 -

Form 253G1 -

Form QUALIF - Notice of Qualification [Regulation A]

Form 1-A POS -

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study

Canopus BioPharma Inc. Announces Results from Compassionate Study in Hepatitis C patients in China

CBIA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Canopus Biopharma Inc (CE) (CBIA) Börsenkurse

Canopus Biopharma Inc (CE) (CBIA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

CBIA Neueste Nachrichten

Form 1-A-W - Withdrawal of offering statement [Regulation A]

Form 1-A POS -

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 253G2 -

Form 253G1 -

Form QUALIF - Notice of Qualification [Regulation A]

Form 1-A POS -

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study

Canopus BioPharma Inc. Announces Results from Compassionate Study in Hepatitis C patients in China

CBIA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen